Chair of the Board since 2021. Chairperson of the Nomination and Remuneration Committee. Member of the Risk and Audit Committee.
Education: MSc. Chemical engineering, Chalmers University of Technology, Gothenburg, Sweden complemented with business studies.
Background: Swedish national with a broad business and leadership experience. Many years of experience in the life science industry and from board work, including as CEO of Kronans Droghandel, Global Health Partner and the Sixth AP Fund, deputy CEO of Apoteket AB, and positions within quality and market development at Pharmacia, Imperial Chemical Industries and Volvo.
Other current positions: Chairman of the Board of Saminvest AB, Sahlgrenska Science Park AB. Board member of Linc AB (publ), Promore Pharma AB and Oblique AB.
Prior positions (past five years): Board member of AdderaCare AB (publ), Enzymatica AB (publ), Camurus AB, Praktikertjänst Aktiebolag and Recipharm AB (publ). Chair of the Royal Swedish Academy of Engineering Sciences (IVA Väst). Member of the Advisory Council of the Dental and Pharmaceutical Agency, TLV.
Holdings in the Company (including related parties): 54,399 shares and no share options.
Independent in relation to the Company and its management and the Company’s major shareholders.